P

Insulet Corp
D

PODD

282.56
USD
-5.82
(-2.02%)
مغلق
حجم التداول
54,706
الربح لكل سهم
4
العائد الربحي
-
P/E
48
حجم السوق
19,820,107,624
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ABT
    ABT
    1.785
    (1.34%)
    134.950 USD
    BSX
    BSX
    -0.840
    (-0.80%)
    104.480 USD
    DXCM
    DXCM
    -0.600
    (-0.67%)
    88.770 USD
    EW
    EW
    -1.380
    (-1.85%)
    73.300 USD
    ISRG
    ISRG
    -15.37
    (-2.53%)
    591.50 USD
    MDT
    MDT
    2.000
    (2.27%)
    89.940 USD
    PFE
    PFE
    0.405
    (1.56%)
    26.305 USD
    T
    TFX
    0.590
    (0.34%)
    175.650 USD
    T
    TNDM
    -1.110
    (-3.45%)
    31.020 USD
    ZBH
    ZBH
    1.250
    (1.21%)
    104.890 USD
    المزيد
الأخبار
المقالات

العنوان: Insulet Corp

القطاع: Healthcare
الصناعة: Medical Devices
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.